## Summary
[ATP6V1E2](/details-gene/90423) encodes the E2 subunit of the vacuolar-type H+-ATPase (V-ATPase), a multi-subunit enzyme complex responsible for proton translocation across membranes. This fundamental process is critical for the acidification of various intracellular compartments, such as lysosomes and endosomes, and for pH homeostasis at the plasma membrane. The expression profile of [ATP6V1E2](/details-gene/90423) highlights its importance in a diverse range of specialized cells. **Overall**, it shows high significance in retinal `[Mueller cell](/details-cell/CL0000636)`, epidermal `[basal cell](/details-cell/CL0000646)`, various neuronal subtypes, and `[CD8-positive, alpha-beta memory T cell, CD45RO-positive](/details-cell/CL0001203)`, suggesting a crucial role in maintaining cellular function across the nervous, integumentary, and immune systems.
## Cellular Roles and Expression Landscape
The expression pattern of [ATP6V1E2](/details-gene/90423) underscores its role as a key component of cellular machinery in metabolically active and specialized cell types.
In the **Overall** context, its highest significance is observed in `[Mueller cell](/details-cell/CL0000636)` (CSI: 2.92), the principal glial cell of the retina, pointing to a vital function in maintaining the retinal microenvironment, potentially through pH regulation and ion transport. Its high significance is also noted in neural cells, including `[caudal ganglionic eminence derived cortical interneuron](/details-cell/CL4023064)` (CSI: 2.13), `[indirect pathway medium spiny neuron](/details-cell/CL4023029)` (CSI: 0.57), and `[direct pathway medium spiny neuron](/details-cell/CL4023026)` (CSI: 0.39), consistent with the V-ATPase's role in synaptic vesicle loading and neurotransmission.
Beyond the nervous system, [ATP6V1E2](/details-gene/90423) is a significant gene in epithelial barrier tissues, as shown by its high CSI in `[basal cell](/details-cell/CL0000646)` (CSI: 2.25) and `[suprabasal keratinocyte](/details-cell/CL4033013)` (CSI: 1.27) of the skin. This suggests a role in skin homeostasis, possibly related to the acidification of the stratum corneum, which is essential for barrier function and desquamation.
Furthermore, its notable significance in `[CD8-positive, alpha-beta memory T cell, CD45RO-positive](/details-cell/CL0001203)` (CSI: 1.93) implicates it in immune function, where V-ATPase activity is required for processes such as endosomal acidification for antigen processing and the function of cytotoxic granules.
## Pathways and Molecular Function
Functionally, [ATP6V1E2](/details-gene/90423) is integral to the V-ATPase complex, directly contributing to `[Proton transmembrane transport](/details-pathway/GO:1902600)` and exhibiting `[Proton-transporting atpase activity, rotational mechanism](/details-pathway/GO:0046961)`. As part of the `[Proton-transporting two-sector atpase complex, catalytic domain](/details-pathway/GO:0033178)`, its activity underpins a vast array of cellular processes.
The gene's involvement in the `[Innate immune system](/details-pathway/R-HSA-168249)` and the broader `[Immune system](/details-pathway/R-HSA-168256)` is consistent with its expression in T cells and its role in `[ROS and RNS production in phagocytes](/details-pathway/R-HSA-1222556)`, where phagosomal acidification is a critical step in pathogen destruction.
Its role in nutrient sensing and metabolic regulation is highlighted by its participation in pathways like `[Amino acids regulate mtorc1](/details-pathway/R-HSA-9639288)` and `[Cellular response to starvation](/details-pathway/R-HSA-9711097)`, where lysosomal V-ATPases act as sensors for intracellular amino acid levels. Additionally, its function in vesicle trafficking and receptor recycling is demonstrated by its connection to `[Transferrin endocytosis and recycling](/details-pathway/R-HSA-917977)` and `[Insulin receptor recycling](/details-pathway/R-HSA-77387)`, processes dependent on proper endosomal pH gradients.
## Research Directions
The widespread yet cell-type-specific significance of [ATP6V1E2](/details-gene/90423) suggests that while it is a core housekeeping gene, its regulation and function are tailored to meet the unique demands of different cellular environments. This provides several avenues for future research.
**Proposed Hypotheses:**
1. Given its high significance in `[CD8-positive, alpha-beta memory T cell, CD45RO-positive](/details-cell/CL0001203)` and its role in the V-ATPase complex, [ATP6V1E2](/details-gene/90423) is likely essential for the acidification of lytic granules, a prerequisite for the proper function of cytotoxic effector proteins like perforin and granzymes. Loss of [ATP6V1E2](/details-gene/90423) function would therefore impair the cytotoxic killing capacity of T cells.
2. The high expression of [ATP6V1E2](/details-gene/90423) in retinal `[Mueller cell](/details-cell/CL0000636)` suggests it plays a critical role in regulating extracellular pH and potassium buffering in the retina. Dysfunctional [ATP6V1E2](/details-gene/90423) in these cells could lead to a toxic microenvironment for photoreceptors and neurons, potentially contributing to the pathogenesis of degenerative retinal diseases like glaucoma or retinitis pigmentosa.
**Experimental Approach:**
To test the first hypothesis regarding the role of [ATP6V1E2](/details-gene/90423) in T cell cytotoxicity, a targeted experimental approach could be employed. Specifically, one could utilize CRISPR-Cas9 to knock out [ATP6V1E2](/details-gene/90423) in primary human `[CD8-positive, alpha-beta T cell](/details-cell/CL0000625)`. The impact on cytotoxic function could be evaluated by co-culturing these engineered T cells with target cancer cells and measuring cell lysis. Concurrently, the pH of intracellular lytic granules could be directly measured using ratiometric pH-sensitive dyes (e.g., LysoSensor) via flow cytometry or confocal microscopy to confirm that the knockout disrupts acidification.
**Therapeutic Potential:**
As a subunit of the essential V-ATPase complex, [ATP6V1E2](/details-gene/90423) presents a challenging therapeutic target due to the high risk of toxicity from systemic inhibition. However, if this specific isoform provides unique functionality or is preferentially expressed in pathological cells (e.g., cancer cells that rely on V-ATPases to manage acidosis from high glycolytic rates), it could offer a therapeutic window. A strategy of inhibition, rather than activation, would be relevant. Developing inhibitors that specifically target the E2 subunit or its assembly into the complex could provide a more targeted approach than general V-ATPase inhibitors, potentially reducing off-target effects and making it a candidate for diseases characterized by aberrant cellular pH regulation.
Disclaimer: This in-silico analysis is generated by an AI language model and may contain inaccuracies or hallucinations. However, it is cross-referenced with curated gene expression data from major biological sources. Please verify the information before use.
